Human PTHrP-(1-36)
Modify Date: 2025-10-11 10:38:24
Human PTHrP-(1-36) structure
|
Common Name | Human PTHrP-(1-36) | ||
|---|---|---|---|---|
| CAS Number | 172867-62-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Human PTHrP-(1-36)Human PTHrP-(1-36) is a secretory form of PTHrP with anticalciuric effects. Human PTHrP-(1-36) enhances beta cell function and proliferation. Human PTHrP-(1-36) can be used in the research of humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism[1][3]. |
| Name | Human PTHrP-(1-36) |
|---|
| Description | Human PTHrP-(1-36) is a secretory form of PTHrP with anticalciuric effects. Human PTHrP-(1-36) enhances beta cell function and proliferation. Human PTHrP-(1-36) can be used in the research of humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism[1][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Human PTHrP-(1-36) (EC50: 0.05 nM) increases intracellular calcium in human epidermal keratinocytes[2]. Human PTHrP-(1-36) (100 nM, 24 h) increases human β-cell proliferation[3]. Human PTHrP-(1-36) (100 nM, 30 min) enhances insulin secretion in human islets[3]. PTHrP-(1-36) (mouse, EC50: 1 nM) induces a rapid Ca2+ response in UMR 106 cells[4]. |
| In Vivo | PTHrP-(1-36) (mouse, 160 μg/kg, s.c., for 5 days/week for 7, 30, or 90 days) enhances beta cell regeneration and increases beta cell mass in a mouse model of partial pancreatectomy[5]. PTHrP-(1-36) (mouse, 100 μg/kg, s.c., every other day) reverses the observed decrease of Wisp1 expression in the diabetic mice[6]. |
| No Any Chemical & Physical Properties |